Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

65.80
Delayed Data
As of May 26
 -3.70 / -5.32%
Today’s Change
31.38
Today|||52-Week Range
80.11
+75.75%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Vaishnaw Akshay K
Senior Vice President-Research & Development
Sale5/15/201732,750$65.00$2.1M-0.30%
Greene Barry E
President
Buy12/01/201655,605$22.75$1.3M+58.25%
Pyott David E I
Director
Buy10/13/201627,900$37.00$1.0M+81.92%
Vaishnaw Akshay K
Senior Vice President-Research & Development
Buy5/15/201732,750$31.39$1.0M-0.30%
Maraganore John M
Chief Executive Officer
Sale12/12/201622,710$42.61$967.7K+54.42%
Maraganore John M
Chief Executive Officer
Sale7/19/201613,571$63.73$864.9K+2.76%
Sharp Phillip Allen
Director
Sale2/01/201720,171$39.72$801.2K+62.67%
Maraganore John M
Chief Executive Officer
Sale7/20/201612,057$65.56$790.5K+0.09%
Sharp Phillip Allen
Director
Buy2/01/201725,000$31.29$782.3K+62.67%
Greene Barry E
President
Sale12/01/201616,976$43.28$734.7K+58.25%
Page of 4